Know Your Numbers. But more importantly, know the trend.

During American Heart Month, we often hear the phrase “Know Your Numbers.” It’s good advice, but it’s incomplete.

Cardiovascular risk is not defined by a single blood pressure reading at a health fair or by a single cholesterol panel ordered during an annual visit. It is defined by directionality over time.

A systolic blood pressure of 132 mmHg may not trigger an alarm.
An LDL of 145 mg/dL may be categorized as “borderline.”
A fasting glucose of 108 mg/dL may not yet qualify as diabetes.

Individually, these values can appear manageable. Longitudinally, they can signal metabolic drift that meaningfully increases cardiovascular risk.

The clinical literature is clear: sustained elevations, even in ranges once considered “mild,” are associated with higher long-term risk of heart attack, stroke, and heart failure. The issue is rarely a catastrophic spike. It is cumulative exposure.

That is the difference between screening and surveillance. Screening identifies a moment in time. Surveillance identifies the trajectory.

For individuals, understanding trendlines enables earlier course correction through nutrition, physical activity, medication optimization, stress management, and sleep regulation.

For employers and health systems, trend visibility enables earlier engagement, targeted interventions, and reduced downstream high-acuity spend.

Prevention is not passive awareness. It is structured visibility.

This American Heart Month, the conversation should move beyond “Have you checked your numbers?”

A more meaningful question is: Do you understand where they are headed?